ANV-Probe: Deteriorative Airborne Neurotropic Virus and Immune Modulation Using a Novel DNA Aptamer-Eggshell Vitelline Membrane Metal-Organic Framework in Caenorhabditis elegans
ISEF · 2026 Translational Medical Science
Overview
Airborne Neurotropic Viruses (ANVs) are emergent invasive neuropathogens, affecting 300-500 million people and being responsible for >700,000 deaths annually. Early neurotropic transcriptomic sequestration is crucial for treating proteotoxicity and DAF-16/FOXO3 longevity pathway dysfunction, yet < 2% of over 1,400 human viral pathogens are medicinally treatable. Thus, my project presents ANV-Probe: the first study to synthesize an avian-inspired, programmable, waste-derived DNA Aptamer–Eggshell Vitelline Membrane Metal-Organic Framework (MOF) (ANV-Probe) for DAF-16/FOXO3 signaling in Caenorhabditis elegans (83% human orthology) as a viable therapeutic target for treating virus-induced neurodegeneration and multi-organ diseases. This study assesses several ANV symptoms, including neuro-muscular impairment, cytotoxicity, germline stress, and viral titre. Methods include in-silico chimeraX docking, sol-gel nucleation, polydopamine coating for eggshell vitelline membrane biofunctionalization, and DNA aptamer conjugation. Pathogenesis molecular assays (Viral MFI) and physiological assays (locomotion, longevity, fecundity) (n=20, N=320), were conducted to assess the efficacy of the ANV-Probe in modulating DAF-16/FOXO3 signaling markers for immune modulation. After extensive experimentation, results achieved impressive (p<0.00001) sub-nanomolar pathogenic absorption, enhanced homeostatic restoration, and upregulated transcriptomic regulation beyond existing non-functionalized therapeutics in resource-limited clinical settings. Bioinformatic simulations of multi-organ ANV-related diseases revealed superior deployable human efficacy. ANV-Probe offers clinicians the first intravenous, bio-programmable, and low-cost nanotechnology therapeutic for neurotropic viral treatment.
Competition history
- ISEF 2026
Resources
Related projects
ISEF · 2016
Applying Viral Nanoparticles in a Treatment Vector for Alzheimer's Disease Using Molecular Dynamics Simulations
JSHS · 2024
The Production of an Anti-PCHD1 Monoclonal Antibody for the Purpose of Combating Hantavirus
ISEF · 2018
Using Unique Ultrashort Inhibitor Peptide as BETA-Amyloid Modulator in C. elegans
JSHS · 2022
Examining the Effect of Schistosoma mansoni on the Development of Peanut Allergy using a Periplaneta americana Model
ISEF · 2020
Identifying Novel Cis-Regulatory Elements in the Viral Genome of Adeno-Associated Virus (AAV) for Increased Genetic Modification Efficiency
ISEF · 2015
Development of a Novel Oncolytic Virus for Cancer Treatment and Diagnosis
ISEF · 2022
Rapid Detection and Inactivation of SARS-CoV-2 with Bio-Conjugated Nanomaterial
ISEF · 2024
Evolving an Epidemic: Optimizing Sialic Acid Receptor Configurations to Increase the Binding Affinity of Avian Influenza H5N1 to Human Cell Glycoproteins
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair